Source:http://linkedlifedata.com/resource/pubmed/id/10435880
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1999-9-14
|
pubmed:abstractText |
Several alterations in growth hormone (GH) secretion have been reported in patients with chronic renal insufficiency. However, cholinergic modulation of somatotopic cell function has not been fully clarified in uraemic patients. To gain further insight into the disrupted mechanism of GH regulation in chronic renal failure, we investigated whether the blockade of cholinergic muscarinic receptor with pirenzepine could modify the response of GH to its physiological releasing hormone.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0931-0509
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1704-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10435880-Administration, Oral,
pubmed-meshheading:10435880-Adult,
pubmed-meshheading:10435880-Growth Hormone-Releasing Hormone,
pubmed-meshheading:10435880-Human Growth Hormone,
pubmed-meshheading:10435880-Humans,
pubmed-meshheading:10435880-Kidney Failure, Chronic,
pubmed-meshheading:10435880-Male,
pubmed-meshheading:10435880-Muscarinic Antagonists,
pubmed-meshheading:10435880-Peritoneal Dialysis,
pubmed-meshheading:10435880-Pirenzepine,
pubmed-meshheading:10435880-Uremia
|
pubmed:year |
1999
|
pubmed:articleTitle |
Effects of cholinergic muscarinic blockade on growth hormone responses to growth hormone-releasing hormone in uraemic patients.
|
pubmed:affiliation |
Department of Endocrinology, Hospital La Paz, Madrid, Spain. mibarsd@infomed-dental.com
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|